Answer
Aug 19, 2026 - 11:42 AM
CagriSema is a combination of two drugs—cagrilintide (an amylin analogue) and semaglutide (a GLP-1 receptor agonist)—while semaglutide alone is just a GLP-1 receptor agonist. Studies suggest that CagriSema may lead to greater weight loss compared to semaglutide alone, likely due to the complementary actions of both components on appetite and metabolism.
